1. Home
  2. DERM vs NKTR Comparison

DERM vs NKTR Comparison

Compare DERM & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • NKTR
  • Stock Information
  • Founded
  • DERM 2014
  • NKTR 1990
  • Country
  • DERM United States
  • NKTR United States
  • Employees
  • DERM N/A
  • NKTR N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • DERM Health Care
  • NKTR Health Care
  • Exchange
  • DERM Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • DERM 181.0M
  • NKTR 160.4M
  • IPO Year
  • DERM 2021
  • NKTR 1994
  • Fundamental
  • Price
  • DERM $8.06
  • NKTR $0.72
  • Analyst Decision
  • DERM Strong Buy
  • NKTR Strong Buy
  • Analyst Count
  • DERM 2
  • NKTR 6
  • Target Price
  • DERM $10.00
  • NKTR $4.92
  • AVG Volume (30 Days)
  • DERM 103.3K
  • NKTR 1.9M
  • Earning Date
  • DERM 05-14-2025
  • NKTR 05-08-2025
  • Dividend Yield
  • DERM N/A
  • NKTR N/A
  • EPS Growth
  • DERM N/A
  • NKTR N/A
  • EPS
  • DERM N/A
  • NKTR N/A
  • Revenue
  • DERM $56,243,000.00
  • NKTR $87,248,000.00
  • Revenue This Year
  • DERM $29.83
  • NKTR N/A
  • Revenue Next Year
  • DERM $54.88
  • NKTR N/A
  • P/E Ratio
  • DERM N/A
  • NKTR N/A
  • Revenue Growth
  • DERM N/A
  • NKTR N/A
  • 52 Week Low
  • DERM $3.54
  • NKTR $0.43
  • 52 Week High
  • DERM $8.24
  • NKTR $1.52
  • Technical
  • Relative Strength Index (RSI)
  • DERM 65.90
  • NKTR 54.57
  • Support Level
  • DERM $6.55
  • NKTR $0.61
  • Resistance Level
  • DERM $7.00
  • NKTR $0.74
  • Average True Range (ATR)
  • DERM 0.63
  • NKTR 0.06
  • MACD
  • DERM 0.13
  • NKTR 0.01
  • Stochastic Oscillator
  • DERM 92.41
  • NKTR 81.79

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: